A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

TNM Classification of Malignant Tumours.

1969 • 1,169 citations

One-Sample Multiple Testing Procedure for Phase II Clinical Trials

1982 • 987 citations

A Proposed New International TNM Staging System for Malignant Pleural Mesothelioma

1995 • 602 citations

Continuing increase in mesothelioma mortality in Britain

1995 • 573 citations

Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

2000 • 458 citations

Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study

1999 • 336 citations

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

1997 • 317 citations

Interaction between cisplatin and gemcitabine in vitro and in vivo.

1995 • 314 citations

Chemotherapy in malignant pleural mesothelioma. A review.

1996 • 229 citations

Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma

2000 • 201 citations

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer.

1997 • 185 citations

Advances in the Treatment of Malignant Pleural Mesothelioma

1999 • 143 citations

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

1999 • 130 citations

Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)

2003 • 107 citations

Gemcitabine Plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Breast Cancer Patients

2000 • 105 citations

Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B

2001 • 101 citations

A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group Study

1988 • 89 citations

Preclinical combination therapy with gemcitabine and mechanisms of resistance.

1996 • 86 citations

Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.

1985 • 81 citations

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

1999 • 79 citations

Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.

1997 • 65 citations

Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery.

1998 • 64 citations

Predictions of future cases of asbestos‐related disease among former miners and millers of crocidolite in Western Australia

1989 • 49 citations

Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma

2000 • 48 citations

The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer

2000 • 46 citations

The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small cell lung cancer.

1998 • 32 citations

Preliminary results of a phase I study with MTA (LY231514) in combination with cisplatin in patients with solid tumors.

1999 • 21 citations

A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma

2000 • 19 citations

Multicenter phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma (MPM)

2000 • 18 citations

Cited By (0)

Loading...